Skip navigation

Cambridge New Therapeutics Forum: February 2016

17:30 - 20:00

Location:
AstraZeneca/MedImmune, Milstein Building, Granta Park, Cambridge. CB21 6GH
Date:
23 February 2016
 
We have now reached full capacity for this event.  To be added to the waiting list, please contact Kate, richardsonk@MedImmune.com



Hosts: AstraZeneca
Date:
 23 February 2016 
Location: MedImmune/AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH


Registration will close at midday on Tuesday 16 February.

Programme: 

17.30 - Doors open (Milstein Building)

18.00 - Welcome from Host

18.10 - Tagrisso – the story of the preclinical and clinical development
Dr. Phil Jewsbury
, Senior Project Director, Oncology iMed, AstraZeneca, Cambridge

Organoids and CRISPR/Cas for autologous cell therapy
Dr. Bon-Kyoung Koo, Group Leader, WT-MRC Cambridge Stem Cell Institute, University of Cambridge

Generation of novel EGFR C797S cellular models through CRISPR/Cas9-driven precise genome engineering for use in drug discovery
Dr. Daniel O’Neill, Senior Research Scientist, Discovery Sciences, AstraZeneca, Cambridge

19.10 - Networking and refreshments

20.00 - Close 

If you require transportations from Cambridge City centre to Granta park, please email Kate Richardson

Please follow us @CamNTF
Please use #CamNTF

Title: Cambridge New Therapeutics Forum: February 2016
Start: 2016-02-23 17:30:00Z
End: 2016-02-23 20:00:00Z